Pentacyclic Triterpenes for Vitiligo Repigmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for vitiligo are cumbersome, costly, and often come with significant side effects, and there is a need for a more effective, accessible, and side-effect-free therapy that can effectively target keratinocytes and melanocytes.
Innovation Solution
A topical composition comprising pentacyclic triterpenes such as Tingenin A, Tingenin B, and Celastrol, or their pharmaceutically acceptable salts, which are administered to slow down, stabilize, or reverse the progression of vitiligo by targeting inflammatory pathways and oxidative stress.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for vitiligo are used, then therapeutic effect is achieved, but treatment complexity and cost increase significantly
Solution Approach 1:
The patent extracts and utilizes specific natural compounds (pentacyclic triterpenes from Tripterygium wilfordii) that possess the therapeutic effects needed for vitiligo treatment, separating the active therapeutic components from complex treatment protocols. This simplifies treatment by focusing on key active ingredients rather than multiple complex procedures
Solution Approach 2:
The patent employs a topical composition that can be applied repeatedly at low cost, replacing expensive and complex medical interventions. The natural compound-based treatment offers an affordable, accessible alternative that does not require sophisticated medical infrastructure or expensive biological molecules
2Reliability
If current treatments for vitiligo are used, then therapeutic effect is achieved, but side effects occur
Solution Approach 1:
The patent utilizes compounds from Tripterygium wilfordii that have known anti-inflammatory and immunomodulatory properties, converting substances with potential toxicity into beneficial therapeutic agents through careful selection and topical application. The natural compounds selectively target pathological processes while sparing healthy tissues
Solution Approach 2:
The topical composition acts as an intermediary that delivers therapeutic effects locally to affected skin areas without requiring systemic administration. This localized delivery minimizes exposure of healthy organs to potential side effects while maintaining therapeutic efficacy at the application site
3Reliability
If current treatments for vitiligo are used, then therapeutic effect is achieved, but accessibility and affordability decrease
Solution Approach 1:
The patent employs a topical composition that can be applied repeatedly at low cost, replacing expensive and complex medical interventions. The natural compound-based treatment offers an affordable, accessible alternative that does not require sophisticated medical infrastructure or expensive biological molecules
Solution Approach 2:
The patent focuses on specific active compounds (pentacyclic triterpenes) that can be extracted and formulated into simple topical preparations, breaking down complex treatment regimens into manageable, affordable components that can be manufactured and distributed widely
Data Source
Figure 1
AI summary
The present invention relates to a composition comprising at least one pentacyclic triterpene or one of the pharmaceutically acceptable salts thereof for use in the treatment and/or prevention of vitiligo.